01 3Olanzapine pamoate
02 5pasireotide
03 1triamcinolone acetonide
04 1triptorelin
05 3triptorelin pamoate
01 1Synergy Health AST, Inc
02 11Synergy Health AST, LLC
03 1Synergy Health, LLC
01 13U.S.A
NDC Package Code : 71161-143
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (300mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-142
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-144
Start Marketing Date : 2009-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (405mg/2.7mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-130
Start Marketing Date : 2018-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-128
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-129
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (10mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-127
Start Marketing Date : 2018-07-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-126
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (30mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-135
Start Marketing Date : 2017-10-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (32mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-106
Start Marketing Date : 2017-09-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
LOOKING FOR A SUPPLIER?
